Literature DB >> 2873731

Characterization of the reproduction of influenza A epidemic viruses in cell cultures.

I N Lavrentieva, T E Medvedeva, D B Golubev.   

Abstract

Two influenza A epidemic viruses with different indices of virulence for humans have been compared with respect to their reproduction in human embryo kidney (HEK), human embryo lung (HEL), and chick embryo kidney (CEK) cell cultures. It has been shown that the highly virulent for humans A/Victoria/35/72 (H3N2) strain reproduced intensively in HEK and HEL cells irrespective of the inoculated dose (multiplicity of infection = 1 EID50 per cell and of 0.001 EID50 per cell, respectively). Efficient infection of a moderately virulent virus A/Bangkok/1/79 (H3N2) was registered in these cell cultures only after addition of trypsin to the maintenance medium. The viruses tested exhibited essentially no difference as to the intensity of their reproduction in CEK cell culture whose sensitivity remained unchanged after addition of trypsin to the maintenance medium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873731

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  3 in total

1.  Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells.

Authors:  Hongquan Wan; Daniel R Perez
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

2.  Chicken interferon alpha pretreatment reduces virus replication of pandemic H1N1 and H5N9 avian influenza viruses in lung cell cultures from different avian species.

Authors:  Haijun Jiang; Hanchun Yang; Darrell R Kapczynski
Journal:  Virol J       Date:  2011-09-22       Impact factor: 4.099

3.  Transcription factor regulation and cytokine expression following in vitro infection of primary chicken cell culture with low pathogenic avian influenza virus.

Authors:  Haijun Jiang; Kangzhen Yu; Darrell R Kapczynski
Journal:  Virol J       Date:  2013-11-19       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.